Lung Cancer Preceptorship
22-23 October, 2021

#TOGAPSHIP21

The TOGA lung cancer preceptorship is an educational meeting for early career clinicians (‘preceptees’) with an interest in lung cancer to learn
  • the critical research that contributes to thoracic cancer standard of care today
  • to critically appraise evidence
Interspersed throughout the event are opportunities for networking, and learning about career development from ‘preceptors’.
Lung cancer preceptorship

The TOGA lung cancer preceptorship is the principal TOGA educational event. The two-day workshop is an intensive and active learning program for medical trainees, fellows and nurses interested in developing their clinical knowledge and expertise in lung cancer management. Under the mentorship of a preceptor, each attendee conducts a critical appraisal of evidence from a published paper that has contributed to current treatment of lung cancer.

During the two-day preceptorship each attendee gives a 10 minute presentation on their allocated paper and the audience is engaged in critical thinking by the presenter and preceptor.

In addition, the preceptorship creates an ideal mentoring environment, where established consultants and trialists describe their careers, illustrating the pathways that the preceptees may wish to take to further their career in thoracic cancer care.

Both structured and unstructured networking opportunities are available to establish mentor-mentee relationships. Various social functions interspersed within the two-day workshop enable preceptees to mingle with colleagues and other preceptors beyond their assigned group.

A session dedicated to development of clinical trials is also included in the program.

Hear preceptors’ and preceptees’ experiences of the 2020 Lung Cancer Preceptorship in a podcast

lung cancer preceptors

Representatives of sponsoring pharmaceutical companies can attend the preceptorship. Please contact TOGA on info@thoraciconcology.org.au to discuss sponsorship options.